{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:08:13Z","timestamp":1759536493285,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1053\/j.ajkd.2008.12.002","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T04:17:03Z","timestamp":1232597823000},"page":"183-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story"],"prefix":"10.1053","volume":"53","author":[{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.ajkd.2008.12.002_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/j.ackd.2006.10.005","article-title":"Chronic kidney disease-mineral-bone disorder: A new paradigm","volume":"14","author":"Moe","year":"2007","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11255-008-9346-7","article-title":"Bone and mineral disorders in pre-dialysis CKD","volume":"40","author":"Kovesdy","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2165\/00126839-200304060-00003","article-title":"Cinacalcet: AMG 073, Calcimimetics\u2013Amgen\/NPS Pharmaceuticals, KRN 1493, NPS 1493","volume":"4","year":"2003","journal-title":"Drugs R D"},{"key":"10.1053\/j.ajkd.2008.12.002_bib5","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1681\/ASN.2007121320","article-title":"Cinacalcet reduces the set point of the PTH-calcium curve","volume":"19","author":"Valle","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1053\/j.ajkd.2007.03.009","article-title":"Parathyroidectomy versus cinacalcet hydrochloride-based medical therapy in the management of hyperparathyroidism in ESRD: A cost utility analysis","volume":"49","author":"Narayan","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1081\/JDI-120028559","article-title":"Successful treatment of severe calciphylaxis in a hemodialysis patient using low-calcium dialysate and medical parathyroidectomy: Case report and literature review","volume":"26","author":"Wang","year":"2004","journal-title":"Ren Fail"},{"key":"10.1053\/j.ajkd.2008.12.002_bib8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1525-139X.2007.00248.x","article-title":"Cinacalcet-induced hungry bone syndrome","volume":"20","author":"Lazar","year":"2007","journal-title":"Semin Dial"},{"key":"10.1053\/j.ajkd.2008.12.002_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.12.002_bib10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000170266","article-title":"High frequency of marked hyperphosphatemia during intravenous calcitriol therapy in hemodialysis patients with refractory hyperparathyroidism","volume":"14","author":"Descombes","year":"1996","journal-title":"Blood Purif"},{"key":"10.1053\/j.ajkd.2008.12.002_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib12","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1053\/j.ajkd.2008.08.012","article-title":"Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism","volume":"53","author":"Serra","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.ki.5002458","article-title":"Paricalcitol aggravates perivascular fibrosis in rats with renal insufficiency and low calcitriol","volume":"72","author":"Repo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib14","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.03790808","article-title":"Cinacalcet lowers serum alkaline phosphatase in maintenance hemodialysis patients","author":"Belozeroff","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.5414\/CNP68245","article-title":"Hypercalciuria induced by a high dose of cinacalcet in a renal-transplant recipient","volume":"68","author":"Esposito","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib16","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e318186b7fb","article-title":"Cinacalcet increases calcium excretion in hypercalcemic hyperparathyroidism after kidney transplantation","volume":"86","author":"Borchhardt","year":"2008","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2008.12.002_bib17","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1053\/ajkd.2002.36899","article-title":"Differential effects of acute administration of 19-Nor-1,25-dihydroxy-vitamin D2 and 1,25-dihydroxy-vitamin D3 on serum calcium and phosphorus in hemodialysis patients","volume":"40","author":"Coyne","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2005.04.013","article-title":"Cinacalcet hydrochloride is an effective treatment for secondary hyperparathyroidism in patients with CKD not receiving dialysis","volume":"46","author":"Charytan","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ncpneph0821","article-title":"Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease","volume":"4","author":"Coyne","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib21","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1600-6143.2007.02136.x","article-title":"Pharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation","volume":"8","author":"Serra","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1053\/j.ajkd.2008.12.002_bib22","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.12.002_bib24","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/ki.2008.64","article-title":"Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib25","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2215\/CJN.01760408","article-title":"Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients","volume":"3","author":"Shinaberger","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib27","article-title":"Kidney bone disease and mortality in CKD: the role of vitamin D, alkaline phosphatase and minerals","author":"Kalantar-Zadeh","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2008.12.002_bib28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ki.2008.35","article-title":"Vitamin D receptor activation and survival in chronic kidney disease","volume":"73","author":"Kovesdy","year":"2008","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/j.1523-1755.2005.00596.x","article-title":"Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism","volume":"68","author":"Cunningham","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1076-7460.2005.04221.x","article-title":"Hypocalcemia, hyperkalemia, and junctional or sinoventricular rhythm","volume":"14","author":"Spodick","year":"2005","journal-title":"Am J Geriatr Cardiol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1076-7460.2005.04228.x","article-title":"Classic chronic renal failure: hyperkalemia and hypocalcemia","volume":"14","author":"Spodick","year":"2005","journal-title":"Am J Geriatr Cardiol"},{"issue":"suppl 3","key":"10.1053\/j.ajkd.2008.12.002_bib34","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.12.002_bib35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/sj.ki.5002412","article-title":"The fallacy of the calcium-phosphorus product","volume":"72","author":"O'Neill","year":"2007","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib36","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.12.002_bib37","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0272-6386(96)90363-7","article-title":"Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients","volume":"27","author":"Braun","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2008.12.002_bib38","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1365-2362.2006.01665.x","article-title":"Vascular calcification and renal osteodystrophy relationship in chronic kidney disease","volume":"36","author":"Moe","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.ajkd.2008.12.002_bib39","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib40","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"73","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"10.1053\/j.ajkd.2008.12.002_bib41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ceca.2003.10.016","article-title":"Calcium-sensing receptor regulation of renal mineral ion transport","volume":"35","author":"Ba","year":"2004","journal-title":"Cell Calcium"},{"key":"10.1053\/j.ajkd.2008.12.002_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib43","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib44","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib45","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.12.002_bib46","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.12.002_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5414\/CNP70126","article-title":"Efficacy of cinacalcet administered with the first meal after dialysis: the SENSOR Study","volume":"70","author":"Schaefer","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP68010","article-title":"Cinacalcet HCI (Sensipar\/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism","volume":"68","author":"Sterrett","year":"2007","journal-title":"Clin Nephrol"},{"key":"10.1053\/j.ajkd.2008.12.002_bib49","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJM197510232931702","article-title":"Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D: Evidence for impaired conversion of 25-hydroxyvitamin D to 1 alpha,25-dihydroxyvitamin D","volume":"293","author":"Kooh","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.12.002_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/TP.0b013e31817c13e1","article-title":"Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism","volume":"86","author":"Bergua","year":"2008","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2008.12.002_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2215\/CJN.03850907","article-title":"Battleground: Chronic kidney disorders mineral and bone disease\u2013calcium obsession, vitamin D, and binder confusion","volume":"3","author":"Kovesdy","year":"2008","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608017216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608017216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:51:06Z","timestamp":1759456266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608017216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0272638608017216"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.002","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is It Worth Correcting Hyperparathyroidism if Hyperphosphatemia and Hypocalcemia Worsen? A Cinacalcet Story","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.09.021","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}